STAT

China rises as a biotech powerhouse, developing drugs to treat the world

Biotech once looked to China for cheap labor. It may soon find mounting competition instead.

Thanks to bountiful investments and loosening regulations, China has become a nascent biotech powerhouse that investors and entrepreneurs say could one day rival the industry’s Western incumbents. Fueled by a sudden influx of foreign-trained talent, a new generation of Chinese startups is racing to treat the world with medicines invented at home.

China’s rapid rise came into relief earlier this month at the annual meeting of the American Society of Clinical Oncology, often called the Super Bowl for biotech stocks because companies race to put out data on experimental

You're reading a preview, sign up to read more.

More from STAT

STAT2 min readPolitics
Biden Puts Forth An Elaborate — And Aggressive — Plan To Lower Drug Prices
His new platform includes some of the most aggressive approaches to lowering drug prices any Democratic presidential candidate has proposed to date. 
STAT10 min readPolitics
How Pharma, Under Attack From All Sides, Keeps Winning In Washington
It’s all President Trump and Democrats on Capitol Hill can agree on. So why hasn’t Washington lowered drug prices?
STAT3 min read
Opinion: I Get Asked A Lot About Longevity. It Helps That I’m 104
As scientists pursue longevity and anti-aging research, we wanted to hear from a centenarian on her life experience and thoughts on aging. So we called one.